Prospects and Management for the Treatment of Autoimmune Diseases
Through medical field to the academic circles, professionals and researchers are urging to invest in immunosuppressive cell-related research, hoping to develop drugs and treatments that can be used to treat autoimmune diseases. However, due to the complexity and particularity of such products, it is necessary for the state to carry out relevant management practices. In addition to the medical and pharmaceutical laws, the Ministry of Health and Welfare announced a draft of the “Cell and Gene Therapy Product Management Act” in 2017. We hope that through the management of specific laws, we will improve the research and development of advanced medical technology and medicines, so that patients can get the best possible treatment immediately.